Karl Egeland

Analyst
Karl Egeland

Karl Egeland has a research and analysis background in various sectors including biotechnology and semiconductor technology. He has contributed to several financial outlets on the topics of immuno-oncology, infectious diseases/vaccines, inflammatory-fibrotic diseases, cell therapy, critical care, hyperinflammation, Alzheimer’s disease, drug formulation technologies, artificial intelligence, transistor materials science and radio frequency (RF) transceiver technology, as well as IP litigation. Karl has a Bachelor of Science in Mechanical Engineering from Grove City College and an Executive MBA from the Jack Welch Management Institute in Washington, DC.

Email Karl

Coverage list